Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Pract
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Technical Guidance for Protein Preservation
What This Product Solves
Proteolytic degradation during cell lysis and sample processing can compromise experimental outcomes, particularly in applications like Western blotting, co-immunoprecipitation, immunofluorescence, and phosphorylation assays. The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) (SKU K1010) is formulated to provide immediate, broad-spectrum inhibition of serine, cysteine, aspartic, and aminopeptidases without introducing EDTA. This ensures compatibility with workflows where preservation of divalent cations (e.g., Mg2+, Ca2+) is required, such as kinase assays and studies of post-translational modifications. Its ready-to-use, DMSO-based 100X concentrate simplifies handling and storage, with a 12-month stability at -20°C. Notably, the EDTA-free profile makes it unsuitable for protocols targeting metalloprotease inhibition via chelation mechanisms.
Protocol Parameters
- Protein Extraction (cell lysates) | 1:100 (v/v) dilution | Use with mammalian, bacterial, or tissue lysates for rapid protease inhibition during lysis | Ensures immediate protection from endogenous proteases and minimizes sample loss | product dossier
- Western Blot Sample Preparation | Add prior to or during lysis buffer preparation | Suitable for workflows requiring native structure preservation and phosphorylation analysis | Prevents proteolytic artifacts that could affect target band detection | product dossier
- Phosphorylation Analysis, Kinase Assays | EDTA-free (no cation chelation) | Critical where divalent cation integrity must be preserved for enzymatic activity | Avoids interference with cation-dependent enzymes, unlike EDTA-containing cocktails | product dossier
- Sample Storage Post-Extraction | Store at -20°C (stable ≥12 months) | Ensures long-term preservation of inhibitor activity and sample integrity | Prevents loss of inhibitor efficacy over multiple freeze-thaw cycles | product dossier
Workflow Setup and QC Checklist
- Pre-cool reagents and equipment: Keep all buffers and tubes on ice before lysis to minimize protease activity pre-inhibition.
- Prepare lysis buffer fresh: Add the Protease Inhibitor Cocktail immediately before use. Avoid premixing with buffers and storing to prevent dilution or degradation.
- Mix thoroughly: After adding at 1:100 (v/v), invert or gently vortex to ensure even distribution throughout the lysate.
- Monitor pH and salt concentration: Confirm compatibility of your lysis buffer with sample type and downstream assay requirements (e.g., for phosphorylation analysis, avoid high phosphate buffers if not needed).
- Aliquot inhibitor stock: To limit freeze-thaw cycles, divide the 100X concentrate into single-use aliquots upon first thaw if processing multiple experiments.
- Include negative controls: For quality control, prepare a lysate without inhibitor to assess potential proteolysis artifacts versus protected samples.
Common Failure Modes and Fixes
-
Observation: Persistent protein degradation despite inhibitor addition.
Potential causes: Insufficient mixing, delayed addition post-lysis, or improper dilution.
Fix: Ensure immediate, thorough mixing at the time of lysis and verify 1:100 dilution accuracy. -
Observation: Loss of enzyme activity in cation-dependent assays.
Potential causes: Use of EDTA-containing inhibitors instead of EDTA-free cocktail.
Fix: Confirm that only the EDTA-free version is used when cation preservation is essential. -
Observation: Precipitation or cloudiness upon addition.
Potential causes: Cold DMSO-based concentrate added to room temperature buffer.
Fix: Pre-equilibrate all reagents to the same temperature and mix gently. -
Observation: Reduced inhibitor efficacy after repeated freeze-thaw cycles.
Potential causes: Use of a single stock aliquot for multiple experiments.
Fix: Aliquot the 100X stock to minimize freeze-thaw events.
Scope and Limitations
This Protease Inhibitor Cocktail is formulated for broad-spectrum inhibition of serine, cysteine, aspartic, and aminopeptidases, making it suitable as a protein extraction protease inhibitor and for workflows involving Western blotting, co-immunoprecipitation, and phosphorylation analysis. Its EDTA-free composition ensures compatibility with applications that require intact divalent cations, including kinase and enzyme assays. However, it does not inhibit metalloproteases that require chelation for effective suppression. For protocols specifically targeting metalloproteases, alternative inhibitor strategies are required. Additionally, the DMSO-based formulation is not ideal for highly DMSO-sensitive systems or if sample volume constraints preclude even minimal DMSO introduction.
For more on scenario-based best practices and comparative guidance, see this article, which details real-world workflow optimization with this cocktail. Further discussion of its mechanistic and strategic role in phosphorylation-sensitive workflows is provided in this companion piece.
Conclusion
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) offers a robust, easy-to-implement solution for the preservation of protein integrity in proteomics workflows that require cation preservation. Its broad-spectrum inhibitor composition, DMSO-based stability, and EDTA-free formulation address common pitfalls in sample preparation for Western blotting, co-immunoprecipitation, and phosphorylation studies. For further application notes and ordering details, refer to the APExBIO product page.